Updated safety and clinical activity results from a phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; pp. viii718 - viii719
Main Authors Pishvaian, M.J., Lee, M.S., Ryoo, B.-Y., Stein, S., Lee, K.-H., Verret, W., Spahn, J., Shao, H., Liu, B., Iizuka, K., Hsu, C.-H.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2018
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy424.028